1. Erythrina velutina Willd. alkaloids: Piecing biosynthesis together from transcriptome analysis and metabolite profiling of seeds and leaves
- Author
-
Arthur Germano Fett-Neto, Norberto Peporine Lopes, Ivanice Bezerra da Silva, Leandro de Santis Ferreira, Rafael Teixeira Freire, Johnatan Vilasboa, J. A. S. Rodrigues, Daisy Sotero Chacon, Jose Angelo Silveira Zuanazzi, Thiago Ferreira de Araújo, Cibele Tesser da Costa, Denise Medeiros Selegato, Katia Castanho Scortecci, Alan Cesar Pilon, Francisco Ayrton Senna Domingos Pinheiro, Alan de Araújo Roque, Eduardo Luiz Voigt, Filippe Lemos Maia Santos, Alberto José Cavalheiro, Renata Libonati, Raquel Brandt Giordani, Leandro Vieira dos Santos, Taffarel Melo Torres, Fernanda Priscila Santos Reginaldo, Federal University of Rio Grande do Norte (UFRN), Rural Federal University of the Semiarid, Institute for Sustainable Development and Environment, University of Florence, Universidade de São Paulo (USP), Federal University of Rio Grande do Sul, Barcelona Institute of Science and Technology, Federal University of Rio Grande do Norte, Federal University of Rio de Janeiro, Brazilian Center for Research in Energy and Materials (CNPEM), and Universidade Estadual Paulista (Unesp)
- Subjects
0301 basic medicine ,Farmacologia ,Erythrina velutina ,Computational biology ,Biology ,DNA sequencing ,Article ,Caatinga ,Transcriptome ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Metabolome ,Benzylisoquinoline ,Benzylisoquinoline Alkaloids ,Erythrina ,ComputingMethodologies_COMPUTERGRAPHICS ,Multidisciplinary ,Velutina ,Farmacology ,Botany ,Fabaceae ,biology.organism_classification ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Botànica ,Targeted metabolite profile - Abstract
Graphical abstract, Introduction Natural products of pharmaceutical interest often do not reach the drug market due to the associated low yields and difficult extraction. Knowledge of biosynthetic pathways is a key element in the development of biotechnological strategies for plant specialized metabolite production. Erythrina species are mainly used as central nervous system depressants in folk medicine and are important sources of bioactive tetracyclic benzylisoquinoline alkaloids (BIAs), which can act on several pathology-related biological targets. Objectives In this sense, in an unprecedented approach used with a non-model Fabaceae species grown in its unique arid natural habitat, a combined transcriptome and metabolome analyses (seeds and leaves) is presented. Methods The Next Generation Sequencing-based transcriptome (de novo RNA sequencing) was carried out in a NextSeq 500 platform. Regarding metabolite profiling, the High-resolution Liquid Chromatography was coupled to DAD and a micrOTOF-QII mass spectrometer by using electrospray ionization (ESI) and Time of Flight (TOF) analyzer. The tandem MS/MS data were processed and analyzed through Molecular Networking approach. Results This detailed macro and micromolecular approach applied to seeds and leaves of E. velutina revealed 42 alkaloids, several of them unique. Based on the combined evidence, 24 gene candidates were put together in a putative pathway leading to the singular alkaloid diversity of this species. Conclusion Overall, these results could contribute by indicating potential biotechnological targets for modulation of erythrina alkaloids biosynthesis as well as improve molecular databases with omic data from a non-model medicinal plant, and reveal an interesting chemical diversity of Erythrina BIA harvested in Caatinga.
- Published
- 2021